75930679
Feb 28, 2000
OLMESARTAN MEDOXOMIL AND OLMESARTAN MEDOXOMIL/ HYDROCHLOROTHIIAZIDE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES INCLUDING HIGH BLOOD PRESSURE, CONGESTIVE HEART FAILURE, DIABETIC NEPHROPATHY ATHEROSCLEROSIS AND STROKE ANGIOTENSIN II RECEPTOR ANTAGONIST
Pharmaceuticals